Migraine

Handbook of Experimental Pharmacology

Volumn 194, Issue , 2009, Pages 75-89

  Benemei, Silvia ^a   Nicoletti, Paola ^a   Capone, Jay G ^a   Cesaris, Francesco De ^a   Geppetti, Pierangelo ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Calcitonin gene related peptide; CGRP receptor; Neurogenic vadodilatation; Primary sensory neurons

Indexed keywords

1 [2 [4 (4 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N METHYLISOCHROMAN 6 CARBOXAMIDE; 1 PIPERIDINECARBOXAMIDE; 1, (4 (2 OXO 2,3 DIHYDRO BENZOIMIDAZOL 1 YL)PIPERIDINE 1 CARBOXYLIC ACID [1 3,5 DIBROMO 4 HYDROXY BENZYL) 2 OXO 2 (4 PHENYL PIPERAZIN 1 YL)ETHYL]AMIDE; 2 ANILINOADENOSINE; 4 (2 METHOXYPHENYL) 2 [2 (2 METHOXYPHENYL)PROPIONYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 OL; 5 (4 FLUOROBENZAMIDO) 3 (1 METHYL 4 PIPERIDINYL) 1H INDOLE FUMARATE; 6 N (2 HYDROXYCYCLOPENTYL)ADENOSINE; [N [6 (2,3 DIFLUOROPHENYL) 2 OXO 1 (2,2,2 TRIFLUOROETHYL)AZEPAN 3 YL] 4 (2 OXO 2,3 DIHYDRO 1H IMIDAZO[4,5 B]PYRIDIN 1 YL)PIPERIDINE 1 CARBOXAMIDE; [N METHYL N (2 METHYLPHENYL) 3 NITRO 4 (2 THIAZOLYLSULFINYL)NITROBENZANILIDE]; ACETYLCHOLINE; ADENOSINE; ANTIMIGRAINE AGENT; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; DIHYDROERGOTAMINE; ERGOTAMINE; LANEPITANT; METRIFUDIL; MK 0974; N [2 [[5 AMINO 1 [[4 (4 PYRIDINYL) 1 PIPERAZINYL]CARBONYL]PENTYL]AMINO] 1 [(3,5 DIBROMO 4 HYDROXYPHENYL)METHYL] 2 OXOETHYL] 4 (1,4 DIHYDRO 2 OXO 3(2H)QUINAZOLINYL; OLCEGEPANT; PLACEBO; RIZATRIPTAN; SB 273779; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1B RECEPTOR; SUMATRIPTAN; TELCAGEPANT; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZOLMITRIPTAN; ANALGESIC AGENT; CALCITONIN GENE RELATED PEPTIDE RECEPTOR;

CARDIOVASCULAR DISEASE; CELL FUNCTION; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EFFERENT NERVE; HUMAN; MIGRAINE; NAUSEA; NEUROBIOLOGY; NEUROGENIC INFLAMMATION; NOCICEPTION; NONHUMAN; PAIN; PARESTHESIA; PHONOPHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; REVIEW; SENSORY NERVE CELL; TRIGEMINAL NERVE; UNSPECIFIED SIDE EFFECT; VASODILATATION; ANIMAL; BRAIN CIRCULATION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; SENSORY NERVE; SENSORY RECEPTOR;

AFFERENT PATHWAYS; ANALGESICS; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CEREBROVASCULAR CIRCULATION; EFFERENT PATHWAYS; HUMANS; MIGRAINE DISORDERS; NEUROGENIC INFLAMMATION; PAIN; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SENSORY RECEPTOR CELLS; TRIGEMINAL NERVE; VASODILATION;

EID: 70349916111     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-79090-7_3     Document Type: Review

References (77)

1. Aiyar N, Daines RA, Disa J et al (2001) Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist. J Pharmacol Exp Ther 296:768-775
2. Alessandri-Haber N, Yeh JJ, Boyd AE et al (2003) Hypotonicity induces TRPV4-mediated nociception in rat. Neuron 39:497-511
3. Amara SG, Arriza JL, Leff SE et al (1985) Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229:1094-1097
4. Baluk P, Bertrand C, Geppetti P et al (1995) NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiol 268:L263-L269
5. Bandell M, Story GM, Hwang SW et al (2004) Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41:849-857
6. Bautista DM, Jordt SE, Nikai T et al (2006) TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124:1269-1282
7. Bautista DM, Siemens J, Glazer JM et al (2007) The menthol receptor TRPM8 is the principal detector of environmental cold. Nature 448:204-208
8. Bevan S, Geppetti P (1994) Protons: small stimulants of capsaicin-sensitive sensory nerves. Trends Neurosci 17:509-512
9. Boeglin D, Hamdan FF, Melendez RE et al (2007) Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor. J Med Chem 50:1401-1408
10. Fluhmann B, Muff R, Hunziker W et al (1995) A human orphan calcitonin receptor-like structure. Biochem Biophys Res Commun 206:341-347
11. Franco-Cereceda A (1991) Calcitonin gene-related peptide and human epicardial coronary arteries: presence, release and vasodilator effects. Br J Pharmacol 102:506-510
12. Gazzieri D, Trevisani M, Springer J et al (2007) Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury. Free Radic Biol Med. 43:581-589
13. Geppetti P, Holzer P (1996) Neurogenic inflammation. CRC, Boca Raton
14. Geppetti P, Del Bianco E, Cecconi R et al (1992) Capsaicin releases calcitonin gene-related peptide from the human iris and ciliary body in vitro. Regul Pept 41:83-92
15. Giffin NJ, Kowacs F, Libri V et al (2003) Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia 23:287-292
16. Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183-187
17. Goadsby PJ, Lipton RB, Ferrari MD (2002a) Migraine - current understanding and treatment. New Engl J Med 346:257-270
18. Goadsby PJ, Hoskin KL, Storer RJ et al (2002b) Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 125:1392-1401
19. Goldstein DJ, Wang O, Saper JR et al (1997) Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia 17:785-790 (Pubitemid 27505105)
20. Goldstein J, Roon I, Offen W et al (1999) Migraine treatment with selective with 5-ht1F receptor agonist (SSOFRA) LY334370. Cephalalgia 19:318
21. Gomez-Mancilla B, Cutler N, Leibowitz M et al (2001) Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine. Cephalalgia 21:727-732
22. Graham J, Wolff H (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39:737-763
23. Gray DW, Marshall I (1992) Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol 107:691-696
24. Ho TW, Mannix LK, Fan X et al (2007) Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine. Neurology 70:1304-1312
25. Huang SM, Bisogno T, Trevisani M et al (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99:8400-8405
26. Humphrey PP, Bland-Ward PA, Carruthers AM et al (2001) Inhibition of trigemnial nociceptive afferents by adenosine A1 receptor activation: a novel approach towards the design of new anti-migraine compounds. Cephalalgia 21:268-269
27. Hwang SW, Cho H, Kwak J et al (2000) Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97:6155-6156
28. Jordt SE, Bautista DM, Chuang HH et al (2004) Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427:260-265
29. Juhasz G, Zsombok T, Modos EA et al (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461-470
30. Kapoor K, Arulmani U, Heiligers JPC et al (2003) Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. Br J Pharmacol 140:329-338
31. Kitamura K, Kangawa K, Kawamoto Met al (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560
32. Knotkova H, Pappagallo M, Szallasi A (2008) Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain 24:142-154
33. Lance J (1969) Mechanism and management of headache. Butterworths, New York
34. Lassen LH, Haderslev PA, Jacobsen VB et al (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54-61
35. Lennerz JK, Ruhle V, Ceppa EP et al (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277-1299
36. Lewis T (1937) The nocifensor system of nerves and its reactions. Br Med J 194:431-435
37. Liedtke W, Choe Y, Marti-Renom MA et al (2000) Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 103:525-535
38. Macpherson LJ, Geierstanger BH, Viswanath V et al (2005) The pungency of garlic: activation of TRPA1 and TRPV1 in response to allicin. Curr Biol 15:929-934
39. Markowitz S, Saito K, Moskowitz MA (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 7:4129-4136
40. McKemy DD, Neuhausser WM, Julius D (2002) Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416:52-58
41. McLatchie LM, Fraser NJ, Main MJ et al (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339
42. Morris HR, Panico M, Etienne T et al (1984) Isolation and characterization of human calcitonin gene-related peptide. Nature 308:746-748
43. Moskowitz MA, Buzzi MG (1991) Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol 238:S18-S22
44. Mudderry PK, Ghatei MA, Spokes RA et al (1988) Differential expression of [alpha]-CGRP and [beta]-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience 25:195-205
45. Nagata K, Duggan A, Kumar G et al (2005) Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J Neurosci 25:4052-4061
46. Nicoletti P, Trevisani M, Manconi M et al (2008) Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig. Cephalalgia 28:9-17
47. Nilius B, Owsianik G, Voets T et al (2007) Transient receptor potential cation channels in disease. Physiol Rev 87:165-217
48. Njuki F, Nicholl CG, Howard A et al (1993) A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin Sci (Lond) 85:385-388
49. Olesen J, Diener HC, Husstedt IW et al (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104-1110
50. Paone DV, Shaw AW, Nguyen DN et al (2007) Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3- difluorophenyl)-2-oxo-1-(2,2,2- trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo [4,5-b]pyridin-1-yl) piperidine-1-carboxamide (MK-0974). J Med Chem 50:5564-5567
51. Peier AM, Moqrich A, Hergarden AC et al (2002) A TRP channel that senses cold stimuli and menthol. Cell 108:705-715
52. Penfield W, McNaughton M (1940) Dural headache and the innervation of the dura mater. Arch Neurol Psychiatr 44:43-75
53. Petermann J, Born W, Chang J et al (1987) Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord. J Biol Chem 262:542-545
54. Petersen K, Birk S, Lassen L et al (2005) The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 25:139-147
55. Premkumar LS, Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature 408:985-990
56. Quirion R, D Van Rossum, Dumont Y et al (1992) Characterization of CGRP1 and CGRP2 receptor subtypes. Ann N Y Acad Sci 657:88-105
57. Raddino R, Pela G, Manca C et al (1997) Mechanism of action of human calcitonin gene-related peptide in rabbit heart and in human mammary arteries. J Cardiovasc Pharmacol 29:463-470
58. Ramadan NM, Skljarevski V, Phebus LA et al (2003) 5-HT1F receptor agonists in acute migraine treatment: a hypothesis. Cephalalgia 23:776-785
59. Ray B, Wolff H (1940) Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Arch Surg 41:813-856
60. Salvatore CA, Hershey JC, Corcoran HA et al (2008) Pharmacological characterization of MK- 0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2- trifluoroethyl)azepan-3-yl]-4-(2-oxo- 2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl) piperidine-1-carbox amide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. J Pharmacol Exp Ther 324:416-421
61. Schoonman GG, van der Grond J, Kortmann C et al (2008) Migraine headache is not associated with cerebral or meningeal vasodilatation - a 3T magnetic resonance angiography study. Brain 131:2192-2200
62. Simone DA, Ochoa J (1991) Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain 47:285-294
63. Smith D, Hill RG, Edvinsson L et al (2002) An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres. Cephalalgia 22:424-431
64. Snider RM, Constantine JW, Lowe JA 3rd et al (1991) A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 251:435-437
65. Story GM, Peier AM, Reeve AJ et al (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112:819-829
66. Struthers AD, Brown MJ, Macdonald DW et al (1986) Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci (Lond) 70:389-393
67. Szallasi A, Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212
68. Szolcsanyi J (1977) A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol 73:251-259
69. Taylor CK, Smith DD, Hulce M et al (2006) Pharmacological characterization of novel alphacalcitonin gene-related peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors. J Pharmacol Exp Ther 319:749-757
70. Tfelt-Hansen P, De Vries P, Saxena PR (2000) Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60:1259-1287
71. Thomsen LL, Iversen HK, Brinck TA et al (1993) Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia 13:395-399
72. Tominaga M, Caterina MJ, Malmberg AB et al (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531-543
73. Trevisani M, Smart D, Gunthorpe MJ et al (2002) Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci 5:546-551
74. Welch KMA (2003) Concepts of migraine headache pathogenesis: insights into mechanisms of chronicity and new drug targets. Neurol Sci 24:S149-S153
75. Williamson DJ, Hill RG, Shepheard SL et al (2001) The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs. Br J Pharmacol 133:1029-1034
76. Wolff H (1948) Headache and other head pain. Oxford University Press, New York, pp 59-97
77. Zygmunt PM, Petersson J, Andersson DA et al (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457